22 Feb, 2024 02:42 PM
INOVIQ Limited (ASX:IIQ or INOVIQ) is excited to announce the successful completion of its breast cancer study.
In a 2023 clinical validation study (n=483), INOVIQ’s SubB2M/CA15-3 test dete...read more
22 Feb, 2024 12:20 PM
Description
The securities of INOVIQ Ltd (‘IIQ’) will be placed in trading halt at the request of IIQ, pending it releasing an announcement. Unless ASX decides otherwise, the sec...read more
14 Feb, 2024 09:12 AM
SYDNEY, AUSTRALIA – 14 February 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing nov...read more
31 Jan, 2024 10:32 AM
“Those who know me from my role as Chairman of PolyNovo (ASX: PNV), know how excited I am to lead a company dedicated to saving lives and improving patient outcomes. We all have family and fri...read more
31 Jan, 2024 08:25 AM
Highlights:
-- icetana has received a US$168,000 (~AUD$250,000), five year order for its AI software solution from Canadian reseller Delco Security.
-- This is the expansion of an existing contrac...read more
30 Jan, 2024 08:32 AM
-- Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer (1L NSCLC) patients expressing PD-L1 (TPS...read more
29 Jan, 2024 08:18 AM
Highlights:
-- icetana has received a S$864,000 (~AUD$980,000), three year order for its AI software solution from Prosegur Singapore.
-- Deployment (programmed for Q3 FY24) will see the existin...read more